Czechia· CZ-0259338
UBRETID
A distigmine product containing distigmine bromide, registered in Czechia by CHEPLAPHARM Arzneimittel GmbH, Greifswald. The same ATC class is registered in 7 of our 19 countries.
Checked against SÚKL (Czech Republic) on
Informational only — not a medical device.
Where it is registered
Distigmine is registered in 7 of 19 countries.
Countries holding a registration under ATC N07AA03 (distigmine), each read from that country’s own register.
- This record: Czechia, from SÚKL (Czech Republic)
- 3 of them publish a price we can compare per daily dose
Distigmine · ATC N07AA03
7 / 19 countries
- Czechiaprice
- Finlandprice
- Germany
- Japan
- Netherlands
- Polandprice
- United Kingdom
The record
At a glance
SÚKL (Czech Republic)- Active substance
- DISTIGMINE BROMIDE
- Manufacturer
- CHEPLAPHARM Arzneimittel GmbH, Greifswald
- Country
- Czechia (CZ)
- ATC code
- N07AA03
- ATC class
- Distigmine
- Defined daily dose
- 5 mg, O
- Reimbursed
- Not published by this register
- Source register
- SÚKL (Czech Republic)
- Last checked
- September 28, 2026
Packs & prices · 1
1 priced- cz_kod_sukl025933850CZK 222.12
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Distigmine in 5 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- PolandUbretidDelfarma Sp. z o.o.
- United KingdomDistigmine bromide 5mg tabletsSpecial Order
- NetherlandsUbretid 5 mg tablettenEuro Registratie Collectief B.V.
- FinlandUbretidNycomed Austria GmbH
- GermanyUbretidCheplapharm Arzneimittel Gmbh
Authorised across Europe · EMA
The same active substance is authorised in 4 EEA countries. Names it is sold under:
- Germany · Ubretid
- Netherlands · Ubretid
- Poland · Ubretid
- Slovakia · Ubretid
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of SÚKL (Czech Republic). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/42d10ddb-1a0e-48a2-ad65-9e0ce6641a50 GET /v1/drugs/42d10ddb-1a0e-48a2-ad65-9e0ce6641a50?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "TBL NOB",
"source": "sukl",
"strength": "5MG",
"pack_size": "50",
"substance": "DISTIGMINE BROMIDE",
"cz_kod_sukl": "0259338",
"product_type": "CH",
"substance_codes": "1903",
"registration_state": "R",
"registration_number": "67/004/70-C"
}See everything about distigmine.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.